Category: Insights

Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents

This paper was originally published by Qiaolei Jiang and Chunjuan Luan in Globalization and Health 2018 14:92 under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Abstract Background Despite the …


How Long Do Drug Patents Last?

Patents filed since 1995 last for 20 years from the date of patent application filing. This is true for “utility” patents, but the terms for certain other, less common types…
The post How Long Do Drug Patents Last? appeared first on DrugPatentWatch – M…


Drug Patent Expirations and Generic Entry Opportunities 2018-2019

In response to requests for a simple generic entry opportunity date for drugs we have leveraged our 1-step dominant patent identification method to produce a continuously-updated list of upcoming patent expirations and generic entry opportunity dates. The list is licensed under a Creative Commons Attribution 4.0 International License, which means you are free to republish it, […]


Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

This article was originally published by Basavaraj S, Guru V. Betageri in Acta Pharmaceutica Sinica B Volume 4, Issue 1, February 2014, Pages 3-17 under a Creative Commons License. Abstract Drug discovery and development…
The post Can formulation and d…


Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?

This paper was originally published by T. Joseph Mattingly, Joseph F. Levy, Julia F. Slejko, Nneka C. Onwudiwe, and Eleanor M. Perfetto in PharmacoEconomics Volume 36, Issue 9 under a Creative Commons…
The post Estimating Drug Costs: How do Manufacture…


Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

This paper was originally published by Toon van der Gronde, Carin A. Uyl-de Groot, and Toine Pieters in PLoS ONE 12(8): e0182613 under a creative commons license. Abstract Context Recent public outcry…
The post Addressing the challenge of high-priced p…


What Happens When a Drug Patent Expires?

The theoretical construct of what happens when drug patents expire is simple and appealing (to consumers, anyway). A name brand drug patent expires, generics are waiting in the wings to…
The post What Happens When a Drug Patent Expires? appeared first …


The US Food and Drug Administration’s tentative approval process and the global fight against HIV

This paper was originally published by Harinder Singh Chahal, Jeffrey S Murray, Martin Shimer, Peter Capella, Ryan Presto, Mary Lou Valdez, and Peter G Lurie in Journal of the International AIDS…
The post The US Food and Drug Administration’s tentative…


Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

This paper was originally published by J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani and Steven V. Molinski in Front. Oncol., 14 November 2017 under a …
The post Giving Drugs a Second Chance: Overc…


Improve Your Litigation Success, Predict Settlement Terms, and Write Better Patents by Analyzing Patent Challenges

Litigation related to drug patents, whether it be direct patent challenges, contract disputes, or other cases, can provide direct intelligence (through disclosures of competitive intelligence) or indirect intelligence through exposure…
The post Improve…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: